(Q24803138)

2

0 references

Anthony Olivieri

3

0 references

Erika Pollex

4

0 references

Marian J Vermeulen

5

0 references

Kurian S Alexander

6

0 references

David J Cain

7

0 references

Irene Cybulsky

8

0 references

Cindy M Hamielec

BMC Cardiovascular Disorders

9

0 references

language of work or name

English

0 references

publication date

22 May 2003

0 references

published in

0 references

volume

3

0 references

issue

1

0 references

page(s)

3

0 references

cites work

Clopidogrel in interventional cardiology: questions answered and questions remaining

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Effect of clopidogrel on bleeding after coronary artery bypass surgery

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

The effects of recent aspirin ingestion on platelet function in cardiac surgical patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Reactive thrombocytosis after coronary bypass surgery. An important risk factor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162165

Effect of aspirin in coronary artery bypass grafting.

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2261-3-3

Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients

21 January 2018

1 reference

12 December 2020

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?

1 reference

12 December 2020

Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials

1 reference

12 December 2020

Early emergent coronary bypass after failed angioplasty

1 reference

12 December 2020

Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators

1 reference

12 December 2020

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients

1 reference

12 December 2020

https://api.crossref.org/works/10.1186%2F1471-2261-3-3

1 reference

7 January 2021